The impact of COVID-19 on health sector stock returns

Erdem Oncu

MPRA Paper from University Library of Munich, Germany

Abstract: Abnormal returns were analyzed using event analysis during the pandemic to investigate whether the impact of COVID-19 on biotech stocks had significant effects. The results show that stocks have positive returns based on cumulative and abnormal average return findings. The devastating effect of the COVID-19 epidemic on the financial sector is observed in the literature. While investors avoid investing in many industries, they still see the healthcare industry profitable. Investors direct their investments towards the profitable sectors of the period. With this crisis, companies in the health sector increased their returns by taking advantage of the pandemic.

Keywords: COVID-19; Health Sector Stock Returns; Abnormal Returns. (search for similar items in EconPapers)
JEL-codes: G00 (search for similar items in EconPapers)
Date: 2021
New Economics Papers: this item is included in nep-fmk
References: View references in EconPapers View complete reference list from CitEc
Citations:

Published in Administrative, Economics and Social Sciences Theory, Current Researches and New Trends 2021,Cetinje, Montenegro: IVPE. (2021): pp. 109-121

Downloads: (external link)
https://mpra.ub.uni-muenchen.de/111032/1/MPRA_paper_111032.pdf original version (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:pra:mprapa:111032

Access Statistics for this paper

More papers in MPRA Paper from University Library of Munich, Germany Ludwigstraße 33, D-80539 Munich, Germany. Contact information at EDIRC.
Bibliographic data for series maintained by Joachim Winter ().